1. Anti‐epileptic drugs induce cutaneous lymphocyte‐associated antigen downregulation leading to potential human herpes virus‐7 reactivation in clinically asymptomatic patients. (10th October 2017) Authors: Caillot, F.; Andrieu, E.; Houivet, E.; Duvert‐Lehembre, S.; Calbo, S.; Sabbah, B.; Maltete, D.; Martinaud, O.; Le Goff, F.; Malekpour, P.; Berard, M.; Rogez, S.; Joly, P.; Picard, D.; Musette, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 2(2018) Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (1st May 2020) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (28th November 2019) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗